PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ALX Oncology Holdings Inc. (ALXO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS00166B1052
CUSIP00166B105
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$423.57M
EPS (TTM)-$3.71
Total Revenue (TTM)$2.48M
Gross Profit (TTM)$1.85M
EBITDA (TTM)-$138.64M
Year Range$3.94 - $17.83
Target Price$21.00
Short %18.50%
Short Ratio4.75

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ALX Oncology Holdings Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in ALX Oncology Holdings Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%FebruaryMarchAprilMayJuneJuly
-79.50%
70.71%
ALXO (ALX Oncology Holdings Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

ALX Oncology Holdings Inc. had a return of -58.70% year-to-date (YTD) and -9.69% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-58.70%15.41%
1 month-11.26%0.33%
6 months-53.79%13.74%
1 year-9.69%21.39%
5 years (annualized)N/A13.11%
10 years (annualized)N/A10.77%

Monthly Returns

The table below presents the monthly returns of ALXO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-3.22%1.80%-23.99%52.65%-37.54%-43.27%-58.70%
2023-17.48%-28.82%-31.72%31.42%12.29%12.59%-18.64%-30.28%12.68%50.00%8.89%89.92%32.12%
2022-25.55%13.25%-6.73%-24.38%-39.98%5.48%19.65%34.30%-26.38%26.85%-8.57%1.53%-47.56%
2021-8.06%1.31%-8.16%-15.03%-9.74%-3.32%7.10%19.54%5.51%-24.13%-42.61%-33.18%-75.07%
20209.00%23.67%-6.68%4.69%94.71%12.05%187.33%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ALXO is 43, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of ALXO is 4343
ALXO (ALX Oncology Holdings Inc.)
The Sharpe Ratio Rank of ALXO is 4040Sharpe Ratio Rank
The Sortino Ratio Rank of ALXO is 5252Sortino Ratio Rank
The Omega Ratio Rank of ALXO is 4949Omega Ratio Rank
The Calmar Ratio Rank of ALXO is 3838Calmar Ratio Rank
The Martin Ratio Rank of ALXO is 3737Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for ALX Oncology Holdings Inc. (ALXO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ALXO
Sharpe ratio
The chart of Sharpe ratio for ALXO, currently valued at -0.12, compared to the broader market-2.00-1.000.001.002.003.00-0.12
Sortino ratio
The chart of Sortino ratio for ALXO, currently valued at 0.67, compared to the broader market-4.00-2.000.002.004.000.67
Omega ratio
The chart of Omega ratio for ALXO, currently valued at 1.08, compared to the broader market0.501.001.502.001.08
Calmar ratio
The chart of Calmar ratio for ALXO, currently valued at -0.14, compared to the broader market0.002.004.006.00-0.14
Martin ratio
The chart of Martin ratio for ALXO, currently valued at -0.48, compared to the broader market-30.00-20.00-10.000.0010.0020.00-0.48
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.82, compared to the broader market-2.00-1.000.001.002.003.001.82
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.59, compared to the broader market-4.00-2.000.002.004.002.59
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.32, compared to the broader market0.501.001.502.001.32
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.45, compared to the broader market0.002.004.006.001.45
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 6.82, compared to the broader market-30.00-20.00-10.000.0010.0020.006.82

Sharpe Ratio

The current ALX Oncology Holdings Inc. Sharpe ratio is -0.12. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of ALX Oncology Holdings Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00FebruaryMarchAprilMayJuneJuly
-0.12
1.82
ALXO (ALX Oncology Holdings Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


ALX Oncology Holdings Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%FebruaryMarchAprilMayJuneJuly
-94.52%
-2.86%
ALXO (ALX Oncology Holdings Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the ALX Oncology Holdings Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ALX Oncology Holdings Inc. was 96.27%, occurring on Aug 28, 2023. The portfolio has not yet recovered.

The current ALX Oncology Holdings Inc. drawdown is 94.52%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.27%Dec 11, 2020681Aug 28, 2023
-27.58%Aug 18, 202032Oct 1, 202028Nov 10, 202060
-17.51%Nov 24, 20202Nov 25, 202010Dec 10, 202012
-7.17%Aug 10, 20202Aug 11, 20203Aug 14, 20205
-4.58%Jul 22, 20201Jul 22, 20204Jul 28, 20205

Volatility

Volatility Chart

The current ALX Oncology Holdings Inc. volatility is 33.77%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%FebruaryMarchAprilMayJuneJuly
33.77%
2.76%
ALXO (ALX Oncology Holdings Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of ALX Oncology Holdings Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

P/E Ratio

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for ALX Oncology Holdings Inc..


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items